Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men. 2013

Lauren M Schwartz, and Philip E Castle, and Stephen Follansbee, and Sylvia Borgonovo, and Barbara Fetterman, and Diane Tokugawa, and Thomas S Lorey, and Vikrant V Sahasrabuddhe, and Patricia Luhn, and Julia C Gage, and Teresa M Darragh, and Nicolas Wentzensen
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville.

BACKGROUND Carcinogenic human papillomaviruses (HPVs) cause a large proportion of anal cancers. Human immunodeficiency virus (HIV)-infected men who have sex with men (MSM) are at increased risk of HPV infection and anal cancer compared with HIV-negative men. We evaluated risk factors for HPV infection and anal precancer in a population of HIV-infected MSM. METHODS Our study included 305 MSM at an HIV/AIDS clinic in the Kaiser Permanente Northern California Health Maintenance Organization. Logistic regression was used to estimate associations of risk factors comparing men without anal HPV infection; men with anal HPV infection, but no precancer; and men with anal precancer. RESULTS Low CD4 count (<350 cells/mm(3)) and previous chlamydia infection were associated with an increased risk of carcinogenic HPV infection (odds ratio [OR], 3.65; 95% confidence interval [CI], 1.28-10.40 and OR, 4.24; 95% CI, 1.16-15.51, respectively). History of smoking (OR, 2.71 95% CI, 1.43-5.14), duration, recency, and dose of smoking increased the risk of anal precancer among carcinogenic HPV-positive men but had no association with HPV infection. CONCLUSIONS We found distinct risk factors for anal HPV infection and anal precancer. Risk factors for HPV infection and anal precancer are similar to established risk factors for cervical cancer progression.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D002140 California State bounded on the east by Nevada and Arizona, on the south by Mexico and the Pacific Ocean on the south and west, and on the north by Oregon.
D002690 Chlamydia Infections Infections with bacteria of the genus CHLAMYDIA. Infections, Chlamydia,Chlamydia Infection,Infection, Chlamydia
D003710 Demography Statistical interpretation and description of a population with reference to distribution, composition, or structure. Demographer,Demographic,Demographic and Health Survey,Population Distribution,Accounting, Demographic,Analyses, Demographic,Analyses, Multiregional,Analysis, Period,Brass Technic,Brass Technique,Demographers,Demographic Accounting,Demographic Analysis,Demographic Factor,Demographic Factors,Demographic Impact,Demographic Impacts,Demographic Survey,Demographic Surveys,Demographic and Health Surveys,Demographics,Demography, Historical,Demography, Prehistoric,Factor, Demographic,Factors, Demographic,Family Reconstitution,Historical Demography,Impact, Demographic,Impacts, Demographic,Multiregional Analysis,Period Analysis,Population Spatial Distribution,Prehistoric Demography,Reverse Survival Method,Stable Population Method,Survey, Demographic,Surveys, Demographic,Analyses, Period,Analysis, Demographic,Analysis, Multiregional,Demographic Analyses,Demographies, Historical,Demographies, Prehistoric,Distribution, Population,Distribution, Population Spatial,Distributions, Population,Distributions, Population Spatial,Family Reconstitutions,Historical Demographies,Method, Reverse Survival,Method, Stable Population,Methods, Reverse Survival,Methods, Stable Population,Multiregional Analyses,Period Analyses,Population Distributions,Population Methods, Stable,Population Spatial Distributions,Prehistoric Demographies,Reconstitution, Family,Reconstitutions, Family,Reverse Survival Methods,Spatial Distribution, Population,Spatial Distributions, Population,Stable Population Methods,Technic, Brass,Technique, Brass
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Lauren M Schwartz, and Philip E Castle, and Stephen Follansbee, and Sylvia Borgonovo, and Barbara Fetterman, and Diane Tokugawa, and Thomas S Lorey, and Vikrant V Sahasrabuddhe, and Patricia Luhn, and Julia C Gage, and Teresa M Darragh, and Nicolas Wentzensen
December 2014, Preventive medicine,
Lauren M Schwartz, and Philip E Castle, and Stephen Follansbee, and Sylvia Borgonovo, and Barbara Fetterman, and Diane Tokugawa, and Thomas S Lorey, and Vikrant V Sahasrabuddhe, and Patricia Luhn, and Julia C Gage, and Teresa M Darragh, and Nicolas Wentzensen
February 2021, Scientific reports,
Lauren M Schwartz, and Philip E Castle, and Stephen Follansbee, and Sylvia Borgonovo, and Barbara Fetterman, and Diane Tokugawa, and Thomas S Lorey, and Vikrant V Sahasrabuddhe, and Patricia Luhn, and Julia C Gage, and Teresa M Darragh, and Nicolas Wentzensen
December 2010, PloS one,
Lauren M Schwartz, and Philip E Castle, and Stephen Follansbee, and Sylvia Borgonovo, and Barbara Fetterman, and Diane Tokugawa, and Thomas S Lorey, and Vikrant V Sahasrabuddhe, and Patricia Luhn, and Julia C Gage, and Teresa M Darragh, and Nicolas Wentzensen
February 2016, LGBT health,
Lauren M Schwartz, and Philip E Castle, and Stephen Follansbee, and Sylvia Borgonovo, and Barbara Fetterman, and Diane Tokugawa, and Thomas S Lorey, and Vikrant V Sahasrabuddhe, and Patricia Luhn, and Julia C Gage, and Teresa M Darragh, and Nicolas Wentzensen
March 2006, AIDS (London, England),
Lauren M Schwartz, and Philip E Castle, and Stephen Follansbee, and Sylvia Borgonovo, and Barbara Fetterman, and Diane Tokugawa, and Thomas S Lorey, and Vikrant V Sahasrabuddhe, and Patricia Luhn, and Julia C Gage, and Teresa M Darragh, and Nicolas Wentzensen
April 2016, Journal of acquired immune deficiency syndromes (1999),
Lauren M Schwartz, and Philip E Castle, and Stephen Follansbee, and Sylvia Borgonovo, and Barbara Fetterman, and Diane Tokugawa, and Thomas S Lorey, and Vikrant V Sahasrabuddhe, and Patricia Luhn, and Julia C Gage, and Teresa M Darragh, and Nicolas Wentzensen
January 2015, The Journal of the Association of Nurses in AIDS Care : JANAC,
Lauren M Schwartz, and Philip E Castle, and Stephen Follansbee, and Sylvia Borgonovo, and Barbara Fetterman, and Diane Tokugawa, and Thomas S Lorey, and Vikrant V Sahasrabuddhe, and Patricia Luhn, and Julia C Gage, and Teresa M Darragh, and Nicolas Wentzensen
January 2011, The Journal of infectious diseases,
Lauren M Schwartz, and Philip E Castle, and Stephen Follansbee, and Sylvia Borgonovo, and Barbara Fetterman, and Diane Tokugawa, and Thomas S Lorey, and Vikrant V Sahasrabuddhe, and Patricia Luhn, and Julia C Gage, and Teresa M Darragh, and Nicolas Wentzensen
January 2011, The Journal of infectious diseases,
Lauren M Schwartz, and Philip E Castle, and Stephen Follansbee, and Sylvia Borgonovo, and Barbara Fetterman, and Diane Tokugawa, and Thomas S Lorey, and Vikrant V Sahasrabuddhe, and Patricia Luhn, and Julia C Gage, and Teresa M Darragh, and Nicolas Wentzensen
January 2020, Oral diseases,
Copied contents to your clipboard!